{
    "2018-04-08": [
        [
            {
                "time": "2018-04-01",
                "original_text": "医药生物行业点评报告：仿制药领域集中受益 一致性评价利好逐步兑现",
                "features": {
                    "keywords": [
                        "仿制药",
                        "一致性评价",
                        "利好",
                        "逐步兑现"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-01",
                "original_text": "医药生物行业跟踪：药店和高质量仿制药企业受益于国务院新政策",
                "features": {
                    "keywords": [
                        "药店",
                        "高质量仿制药",
                        "国务院",
                        "新政策"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-01",
                "original_text": "医药行业重点公司2018年一季报业绩前瞻：聚焦一季报 关注创新+升级主线",
                "features": {
                    "keywords": [
                        "医药",
                        "一季报",
                        "创新",
                        "升级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-01",
                "original_text": "医药行业事件点评：国务院仿制药政策点评：从仿制药大国走向仿制药强国",
                "features": {
                    "keywords": [
                        "国务院",
                        "仿制药",
                        "政策",
                        "强国"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-01",
                "original_text": "医药行业2018年4月份投资月报暨Q2季度策略：创新+升级 从初春到盛夏",
                "features": {
                    "keywords": [
                        "医药",
                        "投资",
                        "创新",
                        "升级",
                        "Q2"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-01",
                "original_text": "医药生物行业简评：仿制药产业沐春风 开启强国之路",
                "features": {
                    "keywords": [
                        "仿制药",
                        "产业",
                        "春风",
                        "强国"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}